Market Cap: $3.3012T 0.460%
Volume(24h): $163.9614B 28.200%
  • Market Cap: $3.3012T 0.460%
  • Volume(24h): $163.9614B 28.200%
  • Fear & Greed Index:
  • Market Cap: $3.3012T 0.460%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$105398.502299 USD

1.75%

ethereum
ethereum

$2555.207592 USD

3.43%

tether
tether

$1.000429 USD

-0.02%

xrp
xrp

$2.141971 USD

2.09%

bnb
bnb

$651.827388 USD

1.41%

solana
solana

$146.611988 USD

2.90%

usd-coin
usd-coin

$0.999805 USD

-0.01%

dogecoin
dogecoin

$0.177273 USD

3.19%

tron
tron

$0.271470 USD

0.86%

cardano
cardano

$0.634997 USD

1.86%

hyperliquid
hyperliquid

$41.657613 USD

9.72%

sui
sui

$3.026449 USD

2.34%

bitcoin-cash
bitcoin-cash

$444.966315 USD

11.29%

chainlink
chainlink

$13.256001 USD

2.72%

unus-sed-leo
unus-sed-leo

$9.032403 USD

1.94%

Cryptocurrency News Articles

Evertz Pharma GmbH Becomes Germany's First Company to Adopt a Strategic Bitcoin Reserve Model

Jun 11, 2025 at 11:58 pm

Evertz Pharma GmbH, a company focusing on premium natural cosmetics, has become Germany's first company to adopt a strategic Bitcoin reserve model

Evertz Pharma GmbH, a company renowned for its premium natural cosmetics, has become the first company in Germany to adopt a strategic Bitcoin reserve model.

According to a press release, the company purchased an additional 100 BTC in May 2025, an amount that is valued at approximately €10 million ($10.8 million).

The adoption marks a continued expansion of the company’s BTC treasury, which began in December 2020 with an initial €2 million Bitcoin purchase.

Since then, Evertz Pharma has regularly allocated corporate profits toward Bitcoin, building a digital reserve aimed at long-term stability.

“Our mission is to promote natural beauty on a scientific foundation,” said Dominik Evertz, Managing Director of Evertz Pharma GmbH. “The same future-focused mindset shapes our financial strategy: Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company.”

The company’s latest acquisition of 100 BTC distinguishes it from industry peers and traditional treasury strategies.

Tobias Evertz, Group CFO stated, “We will continue to invest corporate profits in Bitcoin and are constantly evaluating additional ways to increase our holdings sustainably.”

Unlike publicly traded Bitcoin adopters such as Strategy and Metaplanet, Evertz Pharma operates as a privately held German enterprise.

“Bitcoin is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience. At the same time, we are aligning our financial strategy with the needs of a modern, sustainably operating company,” added Dominik Evertz.

Everetz explains that Bitcoin is a store of value, a hedge against inflation, and a means to diversify reserves. It allows Evertz Pharma to preserve capital without the storage burdens that come with traditional assets like gold. The company’s treasury strategy shows their commitment to financial sustainability.

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Jun 15, 2025